Status:

COMPLETED

Parameters of Cardiac Indices on the Ultrasonic Cardiac Output Monitor As Potential Indicators for Predicting the Achievement of Ultrafiltration Endpoint for Acute Heart Failure Treatment

Lead Sponsor:

Shanghai Tong Ren Hospital

Conditions:

Acute Heart Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Background: The feasibility of the ultrasonic cardiac output monitor (USCOM)applying for determining ultrafiltration (UF) endpoints during acute heart failure (AHF) treatments was evaluated. Methods:...

Detailed Description

This study was based on the ACC/AHA/HFSA guidelines for the management of heart failure and involved 40 patients diagnosed with acute decompensated heart failure (ADHF) from January 2022 to July 2023....

Eligibility Criteria

Inclusion

  • Age ≥ 18 years.
  • Male or non-pregnant female patients.
  • Fluid overload manifested by at least two of the following:
  • Pitting edema ≥ 2+ of the lower extremities
  • Moist rales in the lungs
  • Jugular venous distention \> 10 cm
  • Pulmonary edema or pleural effusion on chest x-ray
  • Paroxysmal nocturnal dyspnea or ≥ two-pillow orthopnea
  • Congestive hepatomegaly or ascites
  • B-type natriuretic peptide (BNP) \> 400 pg/mL

Exclusion

  • Hematocrit \> 45%.
  • Systolic blood pressure ≤ 90 mmHg and poor peripheral circulation.
  • Contraindications to heparin anticoagulation.
  • Renal insufficiency with a Scr ≥ 3.0 mg/dl or planned renal replacement therapies.
  • Acute coronary syndromes.
  • Life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • Active myocarditis.
  • patients with heart failure attributed to restrictive or hypertrophic cardiomyopathy or uncorrected valvular stenotic disease.
  • infection.
  • malignancies.
  • systemic immune disease.
  • unwillingness to cooperate.
  • withdrawal from the study or death.

Key Trial Info

Start Date :

January 5 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06533124

Start Date

January 5 2022

End Date

August 1 2023

Last Update

August 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ShanghaiTongren Hospital

Shanghai, Shanghai Municipality, China, 200336